Copyright © 2016 ·Antria, Inc. All Rights Reserved.

Our Research and Development (‘R&D’) strategy is at the heart of our business model. Through it we deliver pioneering products and services, and drive innovation across the markets we serve. Antria’s primary focus is to demonstrate the safety and efficacy of the Antria Cell Preparation Process.


The Company has:


  • Successfully filed an Investigational New Drug (IND) application

  • Received FDA Approval for a phase 1 and 2 facial fat grafting clinical trial

  • Established patents for Adipolyx™ and Antrialtye



Research and Development 

Research Pipeline

Stem Cell Research